Wird geladen...
Almotriptan 12.5 mg in menstrually related migraine: A randomized, double-blind, placebo-controlled study
Background: Menstrually related migraine (MRM) affects more than half of female migraineurs. Because such migraines are often predictable, they provide a suitable target for treatment in the mild pain phase. The present study was designed to provide prospective data on the efficacy of almotriptan fo...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publications
2011
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3057443/ https://ncbi.nlm.nih.gov/pubmed/20660540 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0333102410378048 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|